Pill Identifier App

125 GG 337 (Levothyroxine 125 mcg (0.125 mg))

Pill imprint 125 GG 337 has been identified as Levothyroxine sodium 125 mcg (0.125 mg).

Levothyroxine is used in the treatment of hashimoto's disease; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test; myxedema coma (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 125 mcg (0.125 mg) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 125 GG 337

Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337
Levothyroxine sodium 125 mcg (0.125 mg) 125 GG 337
Levothyroxine sodium
Imprint:
125
GG 337
Strength:
125 mcg (0.125 mg)
Color:
Beige
Size:
9.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5186
Inactive Ingredients:
magnesium stearate
microcrystalline cellulose
silicon dioxide
sodium starch glycolate type A potato
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68115-0202 Dispensexpress Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)